Last updated 12 days ago
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
830 patients around the world
Available in Chile
Merck Sharp & Dohme Corp.
3Research sites
830Patients around the world
This study is for people with
Solid tumors
Advanced tumors
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
Instituto Oncológico FALP - UIDO
Recruiting
Centro de Estudios Clínicos SAGA - CECSAGA
Recruiting
StudyMK-1084-001
SponsorMerck Sharp & Dohme Corp.
Study typeInterventional
Conditions
Solid tumors
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05067283
